JERUD COZINE: Open Payments
NPI 1508431321 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 32 payments from 12 companies in 2025. Trend: 2023 $416 · 2024 $430 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $143 |
| PFIZER INC. | 5 | $99 |
| Medtronic, Inc. | 4 | $96 |
| Edwards Lifesciences Corporation | 2 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| W. L. Gore & Associates, Inc. | 1 | $31 |
| Boston Scientific Corporation | 1 | $31 |
Products named: REPATHA, COREVALVE EVOLUT R, VYNDAQEL, Kerendia, FARXIGA, SAPIEN 3 Ultra RESILIA, EVKEEZA, JARDIANCE.
Industry payments across IA — which companies pay providers there.
